自己血輸血システム市場レポート：2030年までの動向、予測、競合分析

自己血輸血システムの動向と予測

世界の自己血輸血システム市場は、心臓手術、整形外科手術、臓器移植、外傷処置の各市場における機会により、将来が有望視されています。自己血輸血システムの世界市場は、2024年から2030年にかけてCAGR 5.3％で成長すると予想されます。この市場の主な促進要因は、移植や手術件数の増加、国民の健康意識の高まり、心血管障害や血管障害の増加です。

• Lucintelの予測では、製品別では、予測期間中、自己血輸血製品がより大きなセグメントであり続ける。
• この市場において、用途別では、心臓疾患の罹患率の上昇と心臓手術における自己血輸血の提案により、心臓手術が最大のセグメントであり続けると思われます。
• 地域別では、米国とカナダにおけるがん罹患率の上昇と、地方自治体によるがん啓発活動により、北米が予測期間中に最も高い成長を示すと予想されます。

自己血輸血システム市場の戦略的成長機会

ヘルスケア業界が血液管理のより効率的で費用対効果の高いソリューションを求めていることから、自己血輸血システム市場には数多くの戦略的成長機会が存在します。世界の外科手術の増加と患者の安全性への関心の高まりにより、市場拡大の大きな可能性があります。この分野で事業を展開する企業は、技術革新、地理的拡大、特殊製品の開発を通じて、こうした機会を生かすべく自らを位置づけています。

• 新興市場への地理的拡大：特にアジア太平洋、ラテンアメリカ、中東では、ヘルスケアインフラが成長しつつある新興国市場への進出が市場成長の大きな機会となっています。
• ニッチ用途に特化した機器の開発：特定の外科手術や患者層（小児や老人など）に合わせた自己血輸血システムの開発は、成長の可能性をもたらします。
• AIと自動化の採用拡大：人工知能と自動化を自己血輸血システムに統合することで、効率性の向上、システム機能の強化、運用コストの削減が可能になり、イノベーション主導の成長機会がもたらされます。
• パートナーシップとコラボレーション：病院、研究機関、医療機器企業との戦略的パートナーシップは、最先端技術の開発を促進し、市場開発を拡大します。
• 血液保存と持続可能性の重視：ヘルスケアにおいて持続可能性と資源の最適化が顕著になるにつれ、環境に優しい機能を提供し、外部血液バンクへの依存を低減する自己血輸血システムの需要が高まる。

自己血輸血システム市場は、さまざまな戦略的機会によって大きく成長する見込みです。新興国市場への開発、AIや自動化などの新技術の採用、特殊装置の開発は、主要な成長分野です。これらの機会を活用する企業は、ヘルスケア部門の進化するニーズに対応しながら、ますます競争が激化する市場で成功するための好位置につくでしょう。

自己血輸血システム市場の促進要因・課題

自己血輸血システム市場は、その成長軌道に影響を与える市場促進要因・課題の組み合わせによって形成されています。自己血輸血システムの採用は、その安全性と効率性の利点から増加傾向にありますが、いくつかの要因が市場力学に影響を与えています。これらの促進要因と課題を理解することは、この進化するセクターの複雑さを乗り切ろうとする利害関係者にとって不可欠です。

自己血輸血システム市場の促進要因は以下の通りである：

• 手術手技の増加：手術件数の増加、特に大量出血を伴う手術件数の増加が、自己血輸血システムの需要を促進しています。
• 患者の安全性への関心の高まり：従来の輸血に関連するリスクを最小限に抑え、献血への依存度を減らしたいという願望が、自己血輸血システムの採用を後押ししています。
• 技術の進歩：システム設計、自動化、他の医療技術との統合における革新が、自己血輸血システムをヘルスケアプロバイダーにとってより魅力的なものにしています。
• 血液保存に対する意識の高まり：血液保存に対する意識の高まりが、病院や手術センターでの自己血輸血システムの使用を促進しています。
• 血液管理に対する規制支援：保健当局による支持的な規制と政策が、多くの外科手術における標準治療として自己血輸血システムの採用を促進しています。

課題：

• 初期費用の高さ：特にコストに敏感なヘルスケア環境では、自己血輸血システム導入の初期費用が障壁となる可能性があります。
• 技術的な複雑さ：高度な自己血輸血システムの操作とメンテナンスには専門的なトレーニングが必要であり、そのため普及が制限される可能性があります。
• 代替血液管理ソリューションとの競合：代用血液や細胞サルベージ技術などの競合は、自己血輸血システムに競争圧力を与えます。

自己血輸血システム市場は、手術件数の増加、患者の安全性への関心の高まり、継続的な技術の進歩などの要因によって牽引されています。しかし、高コスト、技術の複雑さ、規制上のハードルといった課題は、依然として普及の障害となっています。市場促進要因・課題に対処しつつ、成長要因を活用することが、市場の勢いを持続させ、継続的な成功を確保する鍵となります。

目次

第1章 エグゼクティブサマリー

第2章 世界の自己血輸血システム市場：市場力学

• イントロダクション、背景、分類
• サプライチェーン
• 業界の促進要因と課題

第3章 2018年から2030年までの市場動向と予測分析

• マクロ経済動向（2018～2023年）と予測（2024～2030年）
• 世界の自己血輸血システム市場の動向（2018～2023年）と予測（2024～2030年）
• 世界の自己血輸血システム市場（タイプ別）
  • 自己血輸血製品
  • 自己血輸血用アクセサリー
• 世界自己血輸血システム市場：用途別
  • 心臓手術
  • 整形外科手術
  • 臓器移植
  • 外傷処置
  • その他

第4章 2018年から2030年までの地域別市場動向と予測分析

• 世界自己血輸血システム市場：地域別
• 北米の自己血輸血システム市場
• 欧州の自己血輸血システム市場
• アジア太平洋地域の自己血輸血システム市場
• その他地域の自己血輸血システム市場

第5章 競合分析

• 製品ポートフォリオ分析
• 運用統合
• ポーターのファイブフォース分析

第6章 成長機会と戦略分析

• 成長機会分析
  • 世界の自己血輸血システム市場のタイプ別成長機会
  • 世界の自己血輸血システム市場の用途別成長機会
  • 世界の自己血輸血システム市場の地域別成長機会
• 世界の自己血輸血システム市場の新たな動向
• 戦略分析
  • 新製品開発
  • 世界の自己血輸血システム市場の能力拡大
  • 世界の自己血輸血システム市場における合併、買収、合弁事業
  • 認証とライセンシング

第7章 主要企業の企業プロファイル

• LivaNova
• Fresenius
• Haemonetics
• Medtronic
• Becton, Dickinson & Company
• Teleflex
• Atrium Medical

Autotransfusion System Trends and Forecast

The future of the global autotransfusion system market looks promising with opportunities in the cardiac surgeries, orthopedic surgeries, organ transplantation, and trauma procedures markets. The global autotransfusion system market is expected to grow with a CAGR of 5.3% from 2024 to 2030. The major drivers for this market are the growing number of transplant and surgery operations, rising health awareness among the population, as well as, increasing rates of cardiovascular and vascular disorders.

• Lucintel forecasts that, within the type category, autotransfusion products will remain a larger segment over the forecast period.
• Within this market, within the application category, cardiac surgeries will remain the largest segment due to the elevated incidence of heart diseases and suggestions for self-blood transfusion in cardiac procedures.
• In terms of regions, North America is expected to witness the highest growth over the forecast period due to growing cancer rates in the United States and Canada, alongside cancer awareness efforts led by local authorities.

Gain valuable insights for your business decisions with our comprehensive 150+ page report.

Emerging Trends in the Autotransfusion System Market

The field of autotransfusion systems has witnessed significant advancements in recent years, driven by the increasing need for safer and more efficient blood management in clinical settings. As medical procedures become more complex, the demand for innovative solutions in transfusion medicine is growing. This has led to emerging trends that aim to improve patient outcomes, reduce healthcare costs, and enhance the overall efficacy of blood conservation during surgeries.

• Integration with Advanced Monitoring Systems: New autotransfusion systems are increasingly being integrated with real-time monitoring tools for better blood management and precise control during procedures.
• Minimally Invasive Techniques: With the rise of minimally invasive surgery, autotransfusion systems are evolving to accommodate smaller incisions and reduced recovery times.
• Automation and Artificial Intelligence: Automation and AI technologies are being incorporated to optimize the blood collection, processing, and reinfusion process, minimizing human error and maximizing efficiency.
• Portable and Compact Devices: Portable autotransfusion devices are emerging, allowing for more flexibility in medical settings and improving the accessibility of blood recovery technologies.
• Focus on Patient Safety and Quality: Innovations focus on ensuring the purity and safety of transfused blood, minimizing the risk of contamination, and optimizing patient outcomes.

The autotransfusion system market is rapidly evolving, with emerging trends focusing on technological integration, patient safety, and efficiency. The industry is witnessing a shift toward automation, portability, and improved blood management strategies, which are set to enhance the future of transfusion medicine. As these trends continue to shape the market, they promise to contribute significantly to patient care and the overall healthcare ecosystem.

Recent Developments in the Autotransfusion System Market

Recent developments in the autotransfusion system market have been driven by a combination of technological innovations and growing demands for safer, more efficient blood management. As healthcare providers strive to reduce the risks associated with traditional blood transfusions, the adoption of autotransfusion systems has surged. These developments are enhancing clinical outcomes, streamlining medical procedures, and addressing challenges in blood supply.

• Technological Advancements in Blood Processing: New systems now incorporate more advanced filters and processing units to enhance the quality of recovered blood, reducing the risk of transfusion-related complications.
• Regulatory Approvals for New Devices: Several new autotransfusion devices have received regulatory approvals, expanding the available range of options for healthcare facilities.
• Expansion of Product Portfolios by Key Players: Major companies in the autotransfusion market have expanded their product portfolios, offering a wider variety of devices that cater to different surgical settings and patient needs.
• Integration with Electronic Health Records (EHR): Modern systems are now integrating seamlessly with EHR systems, providing healthcare professionals with real-time access to patient data, which improves decision-making and workflow.
• Increased Focus on Cost-Effectiveness: As healthcare systems increasingly prioritize cost-effectiveness, autotransfusion devices are becoming more affordable, ensuring broader adoption across hospitals and clinics.

Recent developments in the autotransfusion system market highlight the industry's ongoing innovation and commitment to improving blood management. From regulatory approvals to advanced technological features, these changes are driving the adoption of autotransfusion systems in diverse healthcare settings. These developments are not only enhancing patient safety and procedural outcomes but also addressing the broader challenges of cost and efficiency in modern healthcare.

Strategic Growth Opportunities for Autotransfusion System Market

The autotransfusion system market presents numerous strategic growth opportunities as the healthcare industry seeks more efficient and cost-effective solutions for blood management. With increasing surgical procedures worldwide and a growing focus on patient safety, there is substantial potential for market expansion. Companies operating in the sector are positioning themselves to capitalize on these opportunities through innovation, geographical expansion, and the development of specialized products.

• Geographical Expansion into Emerging Markets: Expanding into developing regions with growing healthcare infrastructures presents a significant opportunity for market growth, particularly in Asia-Pacific, Latin America, and the Middle East.
• Development of Specialized Devices for Niche Applications: Developing autotransfusion systems tailored to specific surgical procedures or patient demographics (e.g., pediatric or geriatric patients) offers growth potential.
• Increased Adoption of AI and Automation: The integration of artificial intelligence and automation into autotransfusion systems can drive efficiency, enhance system capabilities, and reduce operational costs, presenting opportunities for innovation-driven growth.
• Partnerships and Collaborations: Strategic partnerships with hospitals, research institutions, and medical device companies can facilitate the development of cutting-edge technologies and increase market reach.
• Focus on Blood Conservation and Sustainability: As sustainability and resource optimization becomes more prominent in healthcare, autotransfusion systems that offer eco-friendly features and reduced reliance on external blood banks will see higher demand.

The autotransfusion system market is poised for significant growth driven by various strategic opportunities. Expanding into emerging markets, embracing new technologies like AI and automation, and developing specialized devices are key growth areas. Companies that capitalize on these opportunities will be well-positioned to thrive in an increasingly competitive market while addressing the evolving needs of the healthcare sector.

Autotransfusion System Market Driver and Challenges

The autotransfusion system market is shaped by a combination of drivers and challenges that impact its growth trajectory. While the adoption of autotransfusion systems is on the rise due to their safety and efficiency benefits, several factors are influencing market dynamics. Understanding these drivers and challenges is essential for stakeholders seeking to navigate the complexities of this evolving sector.

Drivers of the autotransfusion system market are as follows:

• Increasing Surgical Procedures: The growing number of surgeries, especially those involving high blood loss, drives the demand for autotransfusion systems.
• Enhanced Patient Safety Concerns: The desire to minimize the risks associated with traditional blood transfusions and reduce reliance on donated blood is driving the adoption of autotransfusion systems.
• Technological Advancements: Innovations in system design, automation, and integration with other medical technologies are making autotransfusion systems more attractive to healthcare providers.
• Rising Awareness of Blood Conservation: Increasing awareness about blood conservation practices is promoting the use of autotransfusion systems in hospitals and surgical centers.
• Regulatory Support for Blood Management: Supportive regulations and policies from health authorities are encouraging the adoption of autotransfusion systems as a standard of care in many surgical procedures.

Challenges:

• High Initial Costs: The upfront cost of acquiring and implementing autotransfusion systems can be a barrier, particularly in cost-sensitive healthcare settings.
• Technical Complexity: The operation and maintenance of advanced autotransfusion systems require specialized training, which can limit their widespread adoption.
• Competition from Alternative Blood Management Solutions: Alternatives like blood substitutes or cell-salvage technologies present competitive pressures to autotransfusion systems.

The autotransfusion system market is driven by factors such as increased surgical volumes, heightened patient safety concerns, and ongoing technological advancements. However, challenges like high costs, technical complexity, and regulatory hurdles remain obstacles to widespread adoption. Addressing these challenges while capitalizing on the drivers of growth will be key to sustaining the momentum of the market and ensuring its continued success.

List of Autotransfusion System Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. Through these strategies autotransfusion system companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the autotransfusion system companies profiled in this report include-

• LivaNova
• Fresenius
• Haemonetics
• Medtronic
• Becton, Dickinson & Company
• Teleflex
• Atrium Medical

Autotransfusion System by Segment

The study includes a forecast for the global autotransfusion system by type, application, and region.

Autotransfusion System Market by Type [Analysis by Value from 2018 to 2030]:

• Autotransfusion Products
• Autotransfusion Accessories

Autotransfusion System Market by Application [Analysis by Value from 2018 to 2030]:

• Cardiac Surgeries
• Orthopedic Surgeries
• Organ Transplantation
• Trauma Procedures
• Other

Autotransfusion System Market by Region [Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Autotransfusion System Market

The autotransfusion system market has seen significant advancements driven by technological innovations, increasing surgical procedures, and a growing emphasis on patient safety. Autotransfusion systems, which allow for the collection and reinfusion of a patient's blood, are becoming increasingly popular in various medical settings. Countries like the United States, China, Germany, India, and Japan are at the forefront of these developments, implementing new technologies and practices that enhance efficiency and safety in blood management.

• United States: Recent trends in the U.S. focus on the implementation of modern techniques in the field of autotransfusion systems. A growing trend is the emergence of mobile and user-friendly devices, such as blood collection devices and blood reinfusion pumps. Furthermore, there is an increased focus on educating healthcare providers on how to use these systems optimally to improve patient care.
• China: Driven by heightened healthcare needs and governmental support for healthcare technology, the autotransfusion system market in China is experiencing explosive growth. Key developments include the design and creation of an advanced blood apparatus that not only improves the quality of care for patients but also optimizes operational performance. Additionally, pharmaceutical companies are promoting products tailored to the needs of local hospitals and clinics through advertising and targeted marketing efforts.
• Germany: German hospitals have made significant progress in the development of autotransfusion devices, particularly through innovations in blood recycling and irrigation systems. The government has also contributed to the adoption of such equipment by formulating laws that prioritize patient welfare and the efficient use of blood. This has led to broader usage of these devices, facilitating their quicker adoption in operating rooms.
• India: The growth of the autotransfusion system market in India is mainly attributed to the increasing number of surgical procedures and a strong focus on patient safety. Recent developments include the introduction of low-cost autotransfusion devices tailored to the local market. Companies are also expanding their distribution channels to improve accessibility within hospitals and clinics across the country.
• Japan: The autotransfusion system market in Japan is primarily driven by technological advancements, innovations, and a focus on meeting patient needs. Recent breakthroughs include the launch of fully automated blood processing devices that help minimize blood contamination while increasing the speed at which blood is returned to patients after surgery. The market is growing rapidly due to strong support from both manufacturers and healthcare institutions.

Features of the Global Autotransfusion System Market

Market Size Estimates: Autotransfusion system market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Autotransfusion system market size by type, application, and region in terms of value ($B).

Regional Analysis: Autotransfusion system market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different type, application, and regions for the autotransfusion system market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the autotransfusion system market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this market or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the autotransfusion system market by type (autotransfusion products and autotransfusion accessories), application (cardiac surgeries, orthopedic surgeries, organ transplantation, trauma procedures, and other), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Autotransfusion System Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global Autotransfusion System Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global Autotransfusion System Market by Type
  • 3.3.1: Autotransfusion Products
  • 3.3.2: Autotransfusion Accessories
• 3.4: Global Autotransfusion System Market by Application
  • 3.4.1: Cardiac Surgeries
  • 3.4.2: Orthopedic Surgeries
  • 3.4.3: Organ Transplantation
  • 3.4.4: Trauma Procedures
  • 3.4.5: Other

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global Autotransfusion System Market by Region
• 4.2: North American Autotransfusion System Market
  • 4.2.1: North American Market by Type: Autotransfusion Products and Autotransfusion Accessories
  • 4.2.2: North American Market by Application: Cardiac Surgeries, Orthopedic Surgeries, Organ Transplantation, Trauma Procedures, and Other
• 4.3: European Autotransfusion System Market
  • 4.3.1: European Market by Type: Autotransfusion Products and Autotransfusion Accessories
  • 4.3.2: European Market by Application: Cardiac Surgeries, Orthopedic Surgeries, Organ Transplantation, Trauma Procedures, and Other
• 4.4: APAC Autotransfusion System Market
  • 4.4.1: APAC Market by Type: Autotransfusion Products and Autotransfusion Accessories
  • 4.4.2: APAC Market by Application: Cardiac Surgeries, Orthopedic Surgeries, Organ Transplantation, Trauma Procedures, and Other
• 4.5: ROW Autotransfusion System Market
  • 4.5.1: ROW Market by Type: Autotransfusion Products and Autotransfusion Accessories
  • 4.5.2: ROW Market by Application: Cardiac Surgeries, Orthopedic Surgeries, Organ Transplantation, Trauma Procedures, and Other

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Autotransfusion System Market by Type
  • 6.1.2: Growth Opportunities for the Global Autotransfusion System Market by Application
  • 6.1.3: Growth Opportunities for the Global Autotransfusion System Market by Region
• 6.2: Emerging Trends in the Global Autotransfusion System Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Autotransfusion System Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Autotransfusion System Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: LivaNova
• 7.2: Fresenius
• 7.3: Haemonetics
• 7.4: Medtronic
• 7.5: Becton, Dickinson & Company
• 7.6: Teleflex
• 7.7: Atrium Medical